These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16785667)

  • 21. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is epidemic intelligence, and how is it being improved in Europe?
    Kaiser R; Coulombier D; Baldari M; Morgan D; Paquet C
    Euro Surveill; 2006 Feb; 11(2):E060202.4. PubMed ID: 16804204
    [No Abstract]   [Full Text] [Related]  

  • 23. Case definitions for diseases under national surveillance.
    Can Commun Dis Rep; 2000 May; 26 Suppl 3():i-iv 1-122. PubMed ID: 11055080
    [No Abstract]   [Full Text] [Related]  

  • 24. Significant increase of hantavirus infections in Germany since the beginning of 2007.
    Koch J; Brockmann SO; Winter C; Kimmig P; Stark K
    Euro Surveill; 2007 May; 12(5):E070503.1. PubMed ID: 17868605
    [No Abstract]   [Full Text] [Related]  

  • 25. What happened to the epidemic in new variant Creutzfeldt-Jakob disease?
    Exley C
    Med Hypotheses; 2009 Jun; 72(6):621-2. PubMed ID: 19246163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders.
    Millar CM; Connor N; Dolan G; Lee CA; Makris M; Wilde J; Winter M; Ironside JW; Gill N; Hill FG
    Haemophilia; 2010 Mar; 16(2):305-15. PubMed ID: 20487442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the future dynamics of disease transmission: risk analysis in the United Kingdom Foresight Programme on the detection and identification of infectious diseases.
    Suk J; Lyall C; Tait J
    Euro Surveill; 2008 Oct; 13(44):pii: 19021. PubMed ID: 19000560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced surveillance of haemolytic uraemic syndrome and other thrombotic microangiopathies in Scotland, 2003-2004.
    Pollock K
    Euro Surveill; 2005 May; 10(5):E050519.5. PubMed ID: 16766829
    [No Abstract]   [Full Text] [Related]  

  • 29. Largest ever Marburg haemorrhagic fever outbreak, Angola.
    Lawrence J; Hill DR
    Euro Surveill; 2005 Apr; 10(4):E050407.2. PubMed ID: 16766805
    [No Abstract]   [Full Text] [Related]  

  • 30. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine spongiform encephalopathy in the United Kingdom: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):691-4. PubMed ID: 8313487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is variant Creutzfeldt-Jakob disease in young children misdiagnosed as Alpers' syndrome? An analysis of a national surveillance study.
    te Water Naudé J; Verity CM; Will RG; Devereux G; Stellitano L
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):910-3. PubMed ID: 15146014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
    Cameron C; Pebody R
    Euro Surveill; 2006 Mar; 11(3):E060302.4. PubMed ID: 16804223
    [No Abstract]   [Full Text] [Related]  

  • 34. Creutzfeldt-Jakob disease. The story so far.
    Dyke M
    Br J Perioper Nurs; 2001 Feb; 11(2):64-8. PubMed ID: 11892337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons from the response to the threat of transfusion-transmitted vCJD in Ireland.
    Murphy WG
    Transfus Clin Biol; 2013 Sep; 20(4):416-21. PubMed ID: 24001606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products.
    Zaman SM; Hill FG; Palmer B; Millar CM; Bone A; Molesworth AM; Connor N; Lee CA; Dolan G; Wilde JT; Gill ON; Makris M
    Haemophilia; 2011 Nov; 17(6):931-7. PubMed ID: 21342369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease and blood transfusion.
    Esmonde TF; Will RG; Slattery JM; Knight R; Harries-Jones R; de Silva R; Matthews WB
    Lancet; 1993 Jan; 341(8839):205-7. PubMed ID: 8093499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies.
    Yang H; Huang Y; Gregori L; Asher DM; Bui T; Forshee RA; Anderson SA
    Transfusion; 2017 Apr; 57(4):924-932. PubMed ID: 28261810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communicable diseases surveillance.
    Commun Dis Intell Q Rep; 2010 Mar; 34(1):68-80. PubMed ID: 20521502
    [No Abstract]   [Full Text] [Related]  

  • 40. First results from the new STI reporting system in Cyprus.
    Euro Surveill; 2005 Jun; 10(6):E050616.4. PubMed ID: 16783102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.